Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Citigroup analyst Scott Gruber downgraded Ovintiv Inc. (NYSE:OVV) from Buy to Neutral and raised the price target from $52 to $62. Ovintiv shares closed at $62.08 on Friday. See how other analysts view this stock.
  • Barclays analyst Etzer Darout downgraded Terns Pharmaceuticals, Inc. (NASDAQ:TERN) from Overweight to Equal-Weight and lowered the price target from $56 to $53. Terns Pharma shares closed at $52.92 on Friday. See how other analysts view this stock.
  • Wedbush analyst Michael Piccolo downgraded Burford Capital Limited (NYSE:BUR) from Outperform to Neutral and cut the price target from $6 to $4.75. Burford Capital shares closed at $4.14 on Friday. See how other analysts view this stock.
  • Raymond James analyst Jayson Bedford downgraded Boston Scientific Corporation (NYSE:BSX) from Strong Buy to Outperform and lowered the price target from $97 to $88. Boston Scientific shares closed at $69.17 on Friday. See how other analysts view this stock.

Considering buying OVV stock? Here’s what analysts think:

Photo via Shutterstock